A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Engels, Melanie ^a,b   Bilgic, Esra ^a   Pinto, Antonio ^a,b   Vasquez, Edwin ^a,b   Wollschläger, Lena ^a,b   Steinbrenner, Holger ^b   Kellermann, Kristine ^c   Akhyari, Payam ^a   Lichtenberg, Artur ^a   Boeken, Udo ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiopulmonary bypass; Deep hypothermic circulatory arrest; IL 6; Ischaemia reperfusion; SIRS; STAT3

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; HEART; KIDNEY; LEUKOCYTOSIS; LIVER; LUNG; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WISTAR RAT;

RATTUS;

EID: 84907912253     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-014-0026-3     Document Type: Article

References (34)

1. Complement and the damaging effects of cardiopulmonary bypass. JK Kirklin, S Westaby, EH Blackstone, JW Kirklin, DE Chenoweth, AD Pacifico, J Thorac Cardiovasc Surg 1983 86 6 845 857 6606084
2. The inflammatory response in cardiac surgery. An up-to-date overview with the emphasis on the role of heat shock proteins (HSPs) 60 and 70. P Kunes, V Lonsky, J Mand'ak, M Brtko, M Kolackova, C Andrys, M Kudlova, J Krejsek, Acta medica (Hradec Kralove) 2007 50 2 93 99
3. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. U Boeken, P Feindt, N Zimmermann, G Kalweit, T Petzold, E Gams, Eur J Cardiothorac Surg 1998 13 5 541 545 10.1016/S1010-7940(98)00062-1 9663535
4. Cell response to surgery. N Ni Choileain, HP Redmond, Arch Surg 2006 141 11 1132 1140 10.1001/archsurg.141.11.1132 17116807
5. Evolving concepts in the pathogenesis of postinjury multiple organ failure. FA Moore, EE Moore, Surg Clin North Am 1995 75 2 257 277 7899997
6. The immune response to surgery and trauma: Implications for treatment. PE Marik, M Flemmer, J Trauma Acute Care Surg 2012 73 4 801 808 10.1097/TA.0b013e318265cf87 22976420
7. Immunosuppression following surgical and traumatic injury. F Kimura, H Shimizu, H Yoshidome, M Ohtsuka, M Miyazaki, Surg Today 2010 40 9 793 808 10.1007/s00595-010-4323-z 20740341
8. Adult respiratory distress syndrome after cardiac surgery. JT Christenson, JM Aeberhard, P Badel, F Pepcak, J Maurice, F Simonet, V Velebit, M Schmuziger, Cardiovasc Surg 1996 4 1 15 21 10.1016/0967-2109(96)83778-1 8634840
9. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. A Prasad, GW Stone, DR Holmes, B Gersh, Circulation 2009 120 21 2105 2112 10.1161/CIRCULATIONAHA.108.814640 19933949
10. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. S Sanada, I Komuro, M Kitakaze, Am J Physiol-Heart C 2011 301 5 1723 H1741 10.1152/ajpheart.00553.2011
11. Predictors of low cardiac output syndrome after isolated mitral valve surgery. M Maganti, M Badiwala, A Sheikh, H Scully, C Feindel, TE David, V Rao, J Thorac Cardiovasc Surg 2010 140 4 790 796 10.1016/j.jtcvs.2009.11.022 20152992
12. Abdominal organ injury after cardiac surgery. EA Hessel, Semin Cardiothorac Vasc Anesth 2004 8 3 243 263 10.1177/108925320400800306 15375483
13. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. JJ Jiménez, JL Iribarren, M Brouard, D Hernández, S Palmero, A Jiménez, L Lorente, P Machado, JM Borreguero, JM Raya, B Martín, R Pérez, R Martínez, ML Mora, J Cardiothorac Surg 2011 6 138 10.1186/1749-8090-6-138 21999189
14. Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model. B Jungwirth, GB Mackensen, M Blobner, F Neff, B Reichart, EF Kochs, G Nollert, J Thorac Cardiovasc Surg 2006 131 4 805 812 10.1016/j.jtcvs.2005.11.017 16580438
15. Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. FJ Lewis, M Taufic, Surgery 1953 33 1 52 59 13015312
16. Hypothermia for aortic surgery. RB Griepp, G Di Luozzo, J Thorac Cardiovasc Surg 2013 145 3, Supplement 56 S58 10.1016/j.jtcvs.2012.11.072 23410782
17. Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats. F de Lange, JM Dieleman, B Jungwirth, CJ Kalkman, Br J Anaesth 2007 99 2 177 183 10.1093/bja/aem116 17548430
18. Protein Kinases in Organ Ischemia and Reperfusion: Journal of Investigative Surgery. LH Toledo-Pereyra, F Lopez-Neblina, AH Toledo, J Invest Surg 2008 21 4 215 226 10.1080/08941930802130149 18615319
19. Mitogen-activated protein kinase (MAPK). J Cuschieri, RV Maier, Crit Care Med 2005 33 12 Suppl 417 S419 10.1097/01.CCM.0000191714.39495.A6 16340409
20. The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43. P Lakkisto, C Csonka, G Fodor, P Bencsik, LM Voipio-Pulkki, P Ferdinandy, K Pulkki, Scand J Clin Lab Invest 2009 69 2 209 218 10.1080/00365510802474392 18946777
21. The myocardial JAK/STAT pathway: from protection to failure. K Boengler, D Hilfiker-Kleiner, H Drexler, G Heusch, R Schulz, Pharmacol Ther 2008 120 2 172 185 10.1016/j.pharmthera.2008.08.002 18786563
22. Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. A Pinto, DT Juniper, M Sanil, L Morgan, L Clark, H Sies, MP Rayman, H Steinbrenner, J Inorg Biochem 2012 114 47 54 10.1016/j.jinorgbio.2012.04.011 22694857
23. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. NM Heinen, VE Putz, JI Gorgens, R Huhn, Y Gruber, C Barthuber, B Preckel, BH Pannen, I Bauer, Shock (Augusta, Ga) 2011 36 1 45 53 10.1097/SHK.0b013e31821d8e77
24. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. JR Bell, P Eaton, MJ Shattock, Clin Exp Pharmacol Physiol 2008 35 2 126 134 17892505
25. Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. PS Wolf, HE Merry, AS Farivar, AS McCourtie, MS Mulligan, J Thorac Cardiovasc Surg 2008 135 3 656 665 10.1016/j.jtcvs.2007.11.026 18329489
26. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. M Friedman, FW Sellke, SY Wang, RM Weintraub, RG Johnson, Circulation 1994 90 5 Pt 2 I262 II268 7955263
27. Role of p38 and JNK in liver ischemia and reperfusion. LA King, AH Toledo, FA Rivera-Chavez, LH Toledo-Pereyra, J Hepatobiliary Pancreat Surg 2009 16 6 763 770 10.1007/s00534-009-0155-x 19680593
28. Hemeoxygenase-1 and renal ischaemia-reperfusion injury. DA Ferenbach, DC Kluth, J Hughes, Nephron Exp Nephrol 2010 115 3 33 e37 10.1159/000313828 20424481
29. Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. YT Chen, TH Tsai, CC Yang, CK Sun, LT Chang, HH Chen, CL Chang, PH Sung, YY Zhen, S Leu, HW Chang, YL Chen, HK Yip, J Transl Med 2013 11 1 270 10.1186/1479-5876-11-270 24161164
30. Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats. Z Wang, Y Liu, Y Han, W Guan, X Kou, J Fu, D Yang, H Ren, D He, L Zhou, C Zeng, Eur J Pharmacol 2013 89 115
31. Circulating Endotoxin and Cytokines after Cardiopulmonary Bypass: Differential Correlation with Duration of Bypass and Systemic Inflammatory Response/Multiple Organ Dysfunction Syndromes. KSA Khabar, MA Elbarbary, F Khouqeer, E Devol, S Al-Gain, Z Al-Halees, Clin Immunol Immunopathol 1997 85 1 97 103 10.1006/clin.1997.4413 9325075
32. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. A Aouifi, V Piriou, P Blanc, H Bouvier, O Bastien, P Chiari, R Rousson, R Evans, JJ Lehot, Br J Anaesth 1999 83 4 602 607 10.1093/bja/83.4.602 10673877
33. Differential Activation of Mitogen-activated Protein Kinases in Ischemic and Anesthetic Preconditioning. R da Silva, T Grampp, T Pasch, MC Schaub, M Zaugg, Anesthesiology 2004 100 1 59 69 10.1097/00000542-200401000-00013 14695725
34. Protective effects of SP600125 on renal ischemia-reperfusion injury in rats. YF Xu, M Liu, B Peng, JP Che, HM Zhang, Y Yan, GC Wang, YC Wu, JH Zheng, J Surg Res 2011 169 1 77 e84 10.1016/j.jss.2011.02.021 21492872